Market Overview The gene therapy for age-related macular degeneration market is emerging as researchers develop genetic interventions targeting the underlying biological mechanisms of vision loss in aging populations. These therapies aim to deliver long-lasting or one-time treatment effects, contrasting with the recurring injection regimens common in current AMD management. The Gene Therapy For...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek